| 网站首页 | 眼科中心 | 协和眼科 | 会议中心 | 医学资源 | 精美图片 | 眼科宝贝 | 协和论坛 | 淘宝网店 | 会员中心 | 帮助中心 | 金币换眼科点 | 申请专业权限 | 
最新公告:     本站新域名:http://www.eyecn.net  [毛进  2006年5月29日]        
您现在的位置: 眼科医生网 >> 会议中心 >> 第11届全国会 >> 眼底病11 >> 正文
专题栏目
更多内容
相关文章
更多内容
532 nm绿激光治疗缺血型视网膜中央静脉阻塞         
532 nm绿激光治疗缺血型视网膜中央静脉阻塞
作者:付  群 文章来源:453003 河南省新乡市新乡医学院第三附属医院眼科 点击数: 更新时间:2006-5-2 21:37:04
Abstract Objective Evaluating the clinical effect of treating ischemic central retinal vein occlusion (ischemic CRVO) by panretinal photocoagulation (PRP) with 532 nm Green Laser. Methods According to the results of fundus fluorescence angiography (FFA),33 cases (36 eyes) had been diagnosed as ischemic CRVO and been observed; and PRP were performed on the cases. After PRP, the cases were examined fundus every 2 weeks, and were performed FFA every 3 months. The regular follow-up lasted for 6 ~ 12 months. Results The visual acuity of the cases was improved in 8 eyes (24.2%) after PRP 6 months, and no changes in 23 eyes (69.7%), and decrease in 5 eyes (15.1%); and 27 eyes (81.8) were proved effective. Conclusion It is safe and effective to treat ischemic CRVO by panretinal photocoagulation with 532 nm green laser.
会议投稿录入:fuqun    责任编辑:毛进 
  • 上一篇会议投稿:

  • 下一篇会议投稿:
  • 【字体: 】【发表评论】【加入收藏】【告诉好友】【打印此文】【关闭窗口
      网友评论:(只显示最新10条。评论内容只代表网友观点,与本站立场无关!)

    | 设为首页 | 加入收藏 | 联系站长 | 友情链接 | 版权申明 |
    眼科医生网 眼科医生网版权所有 @ 1998-2008
    部分文章和资源来源于网络,如果侵犯了您的版权,请指出! 站长:毛进
    信息产业部备案
    *京ICP备05085871